HomeNewsBusinessAll pandemics settle with less frequent oscillations: Dr Gagandeep Kang

All pandemics settle with less frequent oscillations: Dr Gagandeep Kang

India has done better than many other countries with different age structures, infection histories and vaccination coverage in containing the third COVID-19 wave, says Dr Gagandeep Kang, senior virologist and professor, CMC–Vellore.

January 28, 2022 / 12:38 IST
Story continues below Advertisement

Dr Gagandeep Kang is one of India’s foremost virologists and member of the COVID-19 Working Group under the National Technical Advisory Group on Immunisation. She holds the distinction of being the first Indian woman to become a Fellow of the Royal Society. In a conversation about the course of the COVID-19 pandemic in India, she said that while the worst of the Omicron-fuelled surge may be behind, existing vaccines against the coronavirus need to be refined to offer better protection. Dr Kang believes that despite the surge in infections during the third wave, India has done relatively well thanks to the high vaccination coverage and previous history of infections.

Here are some excerpts from her interaction with Moneycontrol:

Story continues below Advertisement

Given that the third COVID-19 wave in India, fuelled by the Omicron variant, seems to be plateauing, can we say that the worst is behind us?

For this wave, the descent has started and we hope that the tapering will be rapid. There is a lag of severe disease behind acute cases, but it is unlikely to be beyond the capacity of the health system.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show